Overexpression of CXXC5 Is a Strong Poor Prognostic Factor in ER+ Breast Cancer

Oncology Letters - Greece
doi 10.3892/ol.2018.8647
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

NOTCH1 Is a Poor Prognostic Factor for Breast Cancer and Is Associated With Breast Cancer Stem Cells

OncoTargets and Therapy
OncologyPharmacology
2016English

C-Met Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer

PLoS ONE
Multidisciplinary
2016English

CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2018English

P2.06-13 Poor Nutritional Status Is a Poor Prognostic Factor in Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Abnormal Fhit Expression Is an Independent Poor Prognostic Factor for Cervical Cancer

British Journal of Cancer
Cancer ResearchOncology
2003English

EphA4 Is a Prognostic Factor in Gastric Cancer

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2013English

PRDX4 Overexpression Is Associated With Poor Prognosis in Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy